Hyperthyroidism causes cardiac dysfunction by mitochondrial impairment and energy depletion
Authors:
- 19 February 2013
- journal article
- research article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 217 (2) , 215-228
Abstract
This study elucidates the role of metabolic remodeling in cardiac dysfunction induced by hyperthyroidism. Cardiac hypertrophy, structural remodeling, and expression of the genes associated with fatty acid metabolism were examined in rats treated with triiodothyronine (T3) alone (8 μg/100 g body weight (BW), i.p.) for 15 days or along with a peroxisome proliferator-activated receptor alpha agonist bezafibrate (Bzf; 30 μg/100 g BW, oral) and were found to improve in the Bzf co-treated condition. Ultrastructure of mitochondria was damaged in T3-treated rat heart, which was prevented by Bzf co-administration. Hyperthyroidism-induced oxidative stress, reduction in cytochromecoxidase activity, and myocardial ATP concentration were also significantly checked by Bzf. Heart function studied at different time points during the course of T3treatment shows an initial improvement and then a gradual but progressive decline with time, which is prevented by Bzf co-treatment. In summary, the results demonstrate that hyperthyroidism inflicts structural and functional damage to mitochondria, leading to energy depletion and cardiac dysfunction.Keywords
This publication has 47 references indexed in Scilit:
- Compromised Myocardial Energetics in Hypertrophied Mouse Hearts Diminish the Beneficial Effect of Overexpressing SERCA2aJournal of Biological Chemistry, 2011
- Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophyCardiovascular Research, 2011
- Cardiac hypertrophy and thyroid hormone signalingHeart Failure Reviews, 2009
- Energy metabolism in heart failure and remodellingCardiovascular Research, 2008
- Mitochondrial oxidative stress and dysfunction in myocardial remodellingCardiovascular Research, 2008
- Measurement of cardiac function using pressure–volume conductance catheter technique in mice and ratsNature Protocols, 2008
- Molecular Mechanisms of Cross-talk between Thyroid Hormone and Peroxisome Proliferator Activated Receptors: Focus on the HeartCardiovascular Drugs and Therapy, 2006
- The Transition From Hypertrophy to FailureCirculation, 2005
- Continuous measurements of plasma protein extravasation with microdialysis after various inflammatory challenges in rat and mouse skinAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Signaling Pathways for Cardiac Hypertrophy and FailureNew England Journal of Medicine, 1999